Trends in pricing and out-of-pocket spending on entecavir among commercially insured patients, 2014-2018
Journal Article uri icon

Overview

abstract

  • This cross-sectional study of health claims from patients with private insurance examines trends in the cost of entecavir prescribed for chronic hepatitis B treatment.

  • Link to Article

    publication date

  • 2022
  • published in

  • JAMA network open  Journal
  • Research

    keywords

  • Drugs and Drug Therapy
  • Economics
  • Hepatitis
  • Additional Document Info

    volume

  • 5
  • issue

  • 1